T005 HHSN26100008 (Old 000509388-T009)TORFP 2018-E03 Prevention of Urinary Bladder Cancer with Two "Clinically-Ready" Agents (Everolimus and Naproxen) when Administered in Combination

Grant

Date/time Interval

  • April 1, 2020 - March 31, 2022
  • Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • HHSN261201500036I
  • Contributor

  • Gregory Kennedy M.D.   Principal Investigator